|
Volumn 94, Issue 3 SUPPL. A, 1993, Pages
|
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAFFEINE;
CIMETIDINE;
CIPROFLOXACIN;
CYCLOSPORIN;
CYTOCHROME P450;
CYTOCHROME P450 ISOENZYME;
DIFLOXACIN;
ENOXACIN;
FLEROXACIN;
GYRASE INHIBITOR;
LOMEFLOXACIN;
NORFLOXACIN;
OFLOXACIN;
PEFLOXACIN;
PHENAZONE;
PIPEMIDIC ACID;
RIFAMPICIN;
RUFLOXACIN;
SPARFLOXACIN;
TEMAFLOXACIN;
THEOPHYLLINE;
TOSUFLOXACIN;
WARFARIN;
CONFERENCE PAPER;
DOSE KIDNEY FUNCTION RELATION;
DOSE LIVER FUNCTION RELATION;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG GLUCURONIDATION;
DRUG HALF LIFE;
DRUG METABOLISM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY CLEARANCE;
LIVER CLEARANCE;
METHYLATION;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
ANTI-INFECTIVE AGENTS, QUINOLONE;
DNA TOPOISOMERASES, TYPE II;
DRUG INTERACTIONS;
HUMAN;
KIDNEY;
LIVER;
|
EID: 0027414911
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (79)
|
References (0)
|